SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Torrent Pharma reports 8% rise in Q3 consolidated net profit

24 Jan 2012 Evaluate

Torrent Pharmaceuticals has reported results for its third quarter ended December 31, 2011.

The company has posted a 6.73% fall in net profit after tax of Rs 61.51 crore for the quarter ended December 31, 2011 as compared to Rs 65.95 crore for the same quarter in the previous year. Total income has increased by 13.96% from Rs 461.37 crore for Q3FY11 to Rs 525.78 crore in the quarter under review.

On the consolidated basis the group has posted a net profit rise of 8.15% to Rs 83.18 crore for the quarter ended December 31, 2011 as compared to Rs 76.91 crore in the same quarter last year. Total Income of the company improved by 20.64% to Rs 698.93 crore for the quarter compared to Rs 579.35 crore in the quarter, year ago.

Torrent Pharma Share Price

4380.35 21.40 (0.49%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×